OHRI MANU (Chief Financial Officer) purchased 50K shares of GT BIOPHARMA, INC. on the open market
Open‑market purchase worth $25.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/10/2023ACC: 0001493152-23-011772
Officer· Chief Financial Officer
Since Feb 2022
+50K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+50K
Price / share
$0.50
Trade value
$25K
% of position
New position
4/6/2023
0.00→50K
Total
Net shares
+50K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/6/2023 | P · Purchase | +50K | $0.50 | $25K | New position | 0.00 | 50K |
| Total | +50K | $25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned100K
Total
100K indirect100K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100K | Indirect |
| Total | 100K | 100K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported